Harvard Law School’s Center for Health Law and Policy Innovation (CHLPI) filed an amicus brief to the U.S. Supreme Court in Zubik v. Burwell, an Affordable Care Act (ACA) challenge set for argument on March 26. The brief asks the Court to affirm Court of Appeals’ decisions upholding the federal policy of maintaining access to free preventive care, including contraceptive services, in employer-sponsored health plans.
A team of researchers from Harvard Law School’s Center for Health Law and Policy Innovation, Brown University’s Department of Medicine, Rhode Island’s Miriam Hospital, Treatment Action Group, and Kirby Institute of Australia, has released findings from a nationwide study of Medicaid policies for the treatment of hepatitis C virus (HCV), which affects over 3 million Americans.
On May 19, the Harvard Law School Center for Health Law and Policy Innovation (CHLPI) launched a campaign to promote federal law and policy reforms for type 2 diabetes prevention and management as part of CHLPI’s broader, multi-phase Providing Access to Healthy Solutions (PATHS) initiative that first worked to strengthen local and state policy to address diet-related health conditions.
While the health care rights of low-income individuals living with chronic illnesses are under attack by interests seeking to undermine the Affordable Care Act, advocacy by Harvard Law School’s Center for Health Law and Policy Innovation (CHLPI) has directly led to one health insurance provider making a significant change to protect its patients.
The Harvard Law School Center for Health Law and Policy Innovation (CHLPI) recently released an insightful and action-oriented report on the landscape of type 2 diabetes in New Jersey. The report serves as a resource for diabetes advocates and offers detailed policy recommendations for the prevention and management of the disease.